This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Reuter Chemische Apparatebau Kg, Janssen Pharmaceutica Nv. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Tobias Wedel: Innovator in Chemical Processes
Introduction
Tobias Wedel is a notable inventor based in Karlsruhe, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of enantiomerically enriched compounds. With a total of four patents to his name, Wedel's work has implications in various applications, especially in pharmaceuticals.
Latest Patents
One of his latest patents is focused on a process for the preparation of enantiomerically enriched 3-aminopiperidine. This invention specifically addresses the production of its R-enantiomer, (R)-3-aminopiperidine. The patent also covers an enantiomerically enriched intermediate of the process and specific acid-addition salts of 3-aminopiperidine, which are useful for obtaining a single enantiomer of APIP. Additionally, it includes crystalline forms of (R)-3-aminopiperidine-dihydrochloride-monohydrate and (S)-3-aminopiperidine-dihydrochloride-monohydrate.
Career Highlights
Throughout his career, Tobias Wedel has worked with reputable companies such as Reuter Chemische Apparatebau GmbH and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to refine his skills and contribute to innovative chemical processes.
Collaborations
Some of his notable coworkers include Karl Reuter and Viktor Meier. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Tobias Wedel's contributions to the field of chemistry, particularly through his patents, highlight his role as an influential inventor. His work continues to impact the development of enantiomerically enriched compounds, showcasing the importance of innovation in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
